Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: Possible action of induced proteins on Alzheimer's disease

Proteomics

Volumn 8, Issue 8, 2008, Pages 1595-1607

  Zhang, Jianhua ^a   Sui, Jianjun ^a   Chi, Bun Ching ^a   Wei, Ning Chen ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

Alzheimer's disease; Cellular protein profile; Ibuprofen; LC MS MS analysis; S enantiomer

Indexed keywords

BINDING PROTEIN; CELL PROTEIN; FATTY ACID SYNTHASE; IBUPROFEN; PHOSPHOGLYCERATE MUTASE; REACTIVE OXYGEN METABOLITE; TRIOSEPHOSPHATE ISOMERASE;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; FATTY ACID SYNTHESIS; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; NEUROBLASTOMA; NEUROBLASTOMA CELL; NEUROPROTECTION; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY;

ALZHEIMER DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; CELL SURVIVAL; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; HUMANS; IBUPROFEN; INDICATORS AND REAGENTS; MASS SPECTROMETRY; NEUROBLASTOMA; PEPTIDE FRAGMENTS; PROTEOME; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEREOISOMERISM;

EID: 42549144042     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700556     Document Type: Article

References (31)

1. Townsend, K. P., Pratico, D., Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J. 2005, 19, 1592-1601.
2. Yan, Q., Zhang, J., Liu, H., Babu-Khan, S. et al., Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J. Neurosci. 2003, 23, 7504-7509.
3. Scharf, S., Mander, A., Ugoni, A., Vajda, F., Christophidis, N., A double-blind, placebo-controlled trial of diclofenac/mis-oprostol in Alzheimer's disease. Neurology 1999, 53, 197-201.
4. Jantzen, P. T., Connor, K. E., Di Carlo, G., Wenk, G. L. et al., Microglial activation and beta-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J. Neurosci. 2002, 22, 2246-2254.
5. McGeer, P. L., McGeer, E. G., Polymorphisms in inflammatory genes and the risk of Alzheimer's disease. Arch. Neurol. 2001, 58, 1790-1792.
6. Adams, S. S., Bresloff, P., Mason, C. G., Pharmacological difference between the optical isomers of Ibuprofen: evidence for metabolic inversion of the (-) isomer. J. Pharm. Pharmacol. 1976, 28, 256.
7. Lim, G. P., Yang, F., Chu, T., Chen, P-p. et al., Ibuprofen reduces inflammation and plaque pathology in a mouse model for Alzheimer's disease. Neurobiol. Aging 2000, 21, 17.
8. Lilley, K. S., Razzaq, A., Dupree, P., Two-dimensional gel electrophoresis: recent advances in sample preparation, detection and quantitation. Curr. Opin. Chem. Biol. 2002, 6, 46-50.
9. Moser, K., White, F. M., Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-MS/MS. J. Proteome. Res. 2006, 5, 98-104.
10. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B. et al., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
11. Rogers, J., Kirby, L. C., Hempelman, S. R., Berry, D. L. et al., Clinical trial of indomethacin in Alzheimer's disease. Neurology 1993, 43, 1609-1611.
12. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B. et al., Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3, 1154-1169.
13. Gygi, S. P., Rist, B, Gerber, S. A., Turecek, F. et al., Quantitative analysis of complex protein mixtures using isotopecoded affinity tags. Nat. Biotechnol. 1999, 17, 994-999.
14. DeSouza, L., Diehl, G., Rodrigues, M. J., Guo, J. et al., Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J. Proteome Res. 2005, 4, 377-386.
15. Keshamouni, V. G., Michailidis, G., Grasso, C. S., Anthwal, S. et al., Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J. Proteome Res. 2006, 5, 1143-1154.
16. Whitlam, J. B., Brown, K. F., Crooks, M. J., Room, G. F., Transsynovial distribution of Ibuprofen in arthritic patients. Clin. Pharmacol. Ther. 1981, 29, 487-492.
17. Bates, K. A., Martins, R. N., Harvey, A. R., Oxidative stress in a rat model of chronic gliosis. Neurobiol. Aging 2007, 28, 995-1008.
18. Lambert, J-C., Bensemain, F., Chapuis, J., Cottel, D., Amouyel, P., Association study of the PIN1 gene with Alzheimer's disease. Neurosci. Lett. 2006, 402, 259-261.
19. Krapfenbauer, K., Engidawork, E., Cairns, N., Fountoulakis, M., Lubec, G., Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res. 2003, 967, 152-160.
20. Yao, J., Taylor, M., Davey, F., Ren, Y. et al., Interaction of amyloid binding alcohol dehydrogenase/A[beta] mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model. Mol. Cell Neurosci. 2007, 35, 377-382.
21. Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N. et al., Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease. Neurobiol. Dis. 2006, 22, 223-232.
22. Cullingford, T. E., The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders. Prostaglandins Leukot. Essent. Fatty Acids 2004, 70, 253-264.
23. Patil, S., Chan, C., Palmitic and stearic fatty acids induce Alzheimer's-like hyperphosphorylation of tau in primary rat cortical neurons. Neurosci. Lett. 2005, 384, 288-293.
24. Meier-Ruge, W., Iwangoff, P., Reichlmeier, K., Neurochemical enzyme changes in Alzheimer's and Pick's disease. Arch. Gerontol. Geriatrics 1984, 3, 161-165.
25. Neve, R. L., McPhie, D. L., The cell cycle as a therapeutic target for Alzheimer's disease. Pharmacol. Therapeutics 2006, 111, 99-113.
26. Sultana, R., Boyd-Kimball, D., Poon, H. F., Cai, J. et al., Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: An approach to understand pathological and biochemical alterations in AD. Neurobiol. Aging 2006, 27, 1564-1576.
27. Zapolska-Downar, D., Naruszewicz, M., Zapolski-Downar, A., Markiewski, M. et al., Ibuprofen inhibits adhesiveness of monocytes to endothelium and reduces cellular oxidative stress in smokers and non-smokers. Eur. J. Clin. Invest. 2000, 30, 1002-1010.
28. Boyd-Kimball, D., Sultana, R., Fai, Poon, H., Lynn, B. C. et al., Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid [beta]-peptide (1-42) into rat brain: Implications for Alzheimer's disease. Neuroscience 2005, 132, 313-324.
29. Nahreini, P., Hovland, A. R., Kumar, B., Andreatta, C. et al., Effects of altered cyclophilin A expression on growth and differentiation of human and mouse neuronal cells. Cell. Mol. Neurobiol. 2001, 21, 65-79.
30. Lie, A. A., Schroder, R., Blumcke, I., Magin, T. M. et al., Plectin in the human central nervous system: predominant expression at pia/glia and endothelia/glia interfaces. Acta Neuropathol. (Berl) 1998, 96, 215-221.
31. Sui, J., Tan, T. L., Zhang, J., Ching, C. B., Chen, W. N., iTRAQ-coupled 2D LC-MS/MS analysis on protein profile in vascular smooth muscle cells incubated with S- and R-enantiomers of propranolol: possible role of metabolic enzymes involved in cellular anabolism and antioxidant activity. J. Proteome Res. 2007, 6, 1643-1651.